Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Jeonghoon, Ha"'
Autor:
So Young Park, Sung Hye Kong, Kyoung Jin Kim, Seong Hee Ahn, Namki Hong, Jeonghoon Ha, Sihoon Lee, Han Seok Choi, Ki-Hyun Baek, Jung-Eun Kim, Sang Wan Kim
Publikováno v:
Endocrinology and Metabolism, Vol 39, Iss 4, Pp 539-551 (2024)
This comprehensive review critically examines the detrimental impacts of endocrine-disrupting chemicals (EDCs) on bone health, with a specific focus on substances such as bisphenol A (BPA), per- and polyfluoroalkyl substances (PFASs), phthalates, and
Externí odkaz:
https://doaj.org/article/3aed9e9bc7934168b308b669a59187bc
Autor:
Jeonghoon Ha, Joonyub Lee, Jin Yu, Hakyoung Park, Jiwon Shinn, Seung-Hwan Lee, Jae-Hyoung Cho, Hun-Sung Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 4, Pp 650-658 (2024)
Background/Aims Statins are common lipid-lowering agents used in dyslipidemia. However, they increase serum creatinine phosphokinase (CPK) levels. Currently, there are no studies on the effect of thyroid-stimulating hormone (TSH) levels on CPK levels
Externí odkaz:
https://doaj.org/article/4f678d1292b645dc9687cbc3b6ee2923
Autor:
Kyoung Jin Kim, Jeonghoon Ha, Sang Wan Kim, Jung-Eun Kim, Sihoon Lee, Han Seok Choi, Namki Hong, Sung Hye Kong, Seong Hee Ahn, So Young Park, Ki-Hyun Baek
Publikováno v:
Endocrinology and Metabolism, Vol 39, Iss 2, Pp 267-282 (2024)
This review article investigates solid organ transplantation-induced osteoporosis, a critical yet often overlooked issue, emphasizing its significance in post-transplant care. The initial sections provide a comprehensive understanding of the prevalen
Externí odkaz:
https://doaj.org/article/415337b69a374e469bf094ceeaca362f
Autor:
Han-Sang Baek, Jeonghoon Ha, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Sungju Kim, Dong-Jun Lim, Chul-Min Kim
Publikováno v:
Endocrinology and Metabolism, Vol 39, Iss 2, Pp 310-323 (2024)
Background There is debate about ultrasonography screening for thyroid cancer and its cost-effectiveness. This study aimed to evaluate the cost-effectiveness of early screening (ES) versus symptomatic detection (SD) for differentiated thyroid cancer
Externí odkaz:
https://doaj.org/article/b522d40261a24557bbc087340eadf9db
Publikováno v:
BMC Musculoskeletal Disorders, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Insurance reimbursement provisions in South Korea limit osteoporosis medication availability for patients with T-scores exceeding − 2.5. This study aimed to evaluate the financial impact and fracture prevention of continuous den
Externí odkaz:
https://doaj.org/article/88a5b760fbde49d48cd5eb56e50505d4
Autor:
Chaiho Jeong, Hansang Baek, Jaewoong Bae, Nakwon Hwang, Jeonghoon Ha, Young-Seok Cho, Dong-Jun Lim
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0300678 (2024)
While several studies have proposed a connection between the gut microbiome and the pathogenesis of Graves's disease (GD), there has been a lack of reports on alteration in microbiome following using anti-thyroid drug treatment (ATD) to treat GD. Sto
Externí odkaz:
https://doaj.org/article/2f9fef5e4b7247798211b694538b94ce
Autor:
Jin Yu, Han-Sang Baek, Chaiho Jeong, Kwanhoon Jo, Jeongmin Lee, Jeonghoon Ha, Min Hee Kim, Jungmin Lee, Dong-Jun Lim
Publikováno v:
Endocrinology and Metabolism, Vol 38, Iss 3, Pp 338-346 (2023)
Background To determine whether baseline thyroid-stimulating immunoglobulin (TSI) bioassay or its early response upon treatment with an anti-thyroid drug (ATD) can predict prognosis of Graves’ disease (GD) in real-world practice. Methods This retro
Externí odkaz:
https://doaj.org/article/d5d4814e35854a6eae5458409f5fec5a
Autor:
Chaiho Jeong, Jeongmin Lee, Jinyoung Kim, Jeonghoon Ha, Kwanhoon Jo, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Tae-Seo Sohn, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek
Publikováno v:
Endocrinology and Metabolism, Vol 38, Iss 2, Pp 260-268 (2023)
Background Persistence with denosumab in male patients has not been adequately investigated, although poor denosumab persistence is associated with a significant risk of rebound vertebral fractures. Methods We retrospectively evaluated 294 Korean mal
Externí odkaz:
https://doaj.org/article/c149c698048541f0bdee4394269117ae
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 3020-3031 (2023)
Recently, selpercatinib, a highly selective inhibitor of RET receptor tyrosine kinase, has been used for RET-altered thyroid cancer. We present four cases of patients with advanced thyroid cancer who were treated with selpercatinib. The first patient
Externí odkaz:
https://doaj.org/article/995c5dce635a4a9089e33b6f9572379f
Autor:
Hyemi Kwon, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, Eun Heui Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Jun Sung Moon, Jin Hwa Kim, Mi-kyung Kim
Publikováno v:
Endocrinology and Metabolism, Vol 37, Iss 6, Pp 839-850 (2022)
Immune checkpoint inhibitors (ICIs) including an anti-cytotoxic T-lymphocyte-associated antigen 4 inhibitor, anti-programmed cell death protein 1 (PD-1) inhibitors, and anti-PD-ligand 1 inhibitors are representative therapeutics for various malignanc
Externí odkaz:
https://doaj.org/article/2fb0bfc93d6c4f40990412e830ec2ee3